Elham Rismani
Impact in
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
Papers in
-
- Wnt/β-catenin signaling in development and cancer 5
- Protein Structure and Dynamics 4
- vaccines and immunoinformatics approaches 4
- Pluripotent Stem Cells Research 3
-
- Nanoparticle-Based Drug Delivery 4
- Co-authors
- Behrooz Johari (7 shared papers)Yousef Mortazavi (2 shared papers)Mehdi Kadivar (3 shared papers)Mahmoud Gharbavi (2 shared papers)Ali Sharafi (2 shared papers)Ladan Teimoori‐Toolabi (4 shared papers)Navid Mousazadeh (1 shared paper)Hamzeh Rahimi (5 shared papers)
In The Last Decade
Elham Rismani
35 papers receiving 312 citations
Peers
Comparison fields: 5 of 49
- Biomaterials 81
- Drug Discovery 1
- Molecular Medicine 15
- Pharmaceutical Science 14
- Oncology 35
Countries citing papers authored by Elham Rismani
This map shows the geographic impact of Elham Rismani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elham Rismani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elham Rismani more than expected).
Fields of papers citing papers by Elham Rismani
This network shows the impact of papers produced by Elham Rismani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elham Rismani. The network helps show where Elham Rismani may publish in the future.
Co-authors
The 25 scholars most cited alongside Elham Rismani, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 39 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 45 | |
| 2 | 2020 | 34 | |
| 3 | 2020 | 33 | |
| 4 | 2017 | 24 | |
| 5 | 2020 | 17 | |
| 6 | 2021 | 15 | |
| 7 | 2023 | 15 | |
| 8 | 2017 | 13 | |
| 9 | 2019 | 12 | |
| 10 | 2024 | 12 | |
| 11 | 2020 | 11 | |
| 12 | 2020 | 9 | |
| 13 | 2019 | 8 | |
| 14 | 2021 | 7 | |
| 15 | 2023 | 7 | |
| 16 | 2020 | 6 | |
| 17 | 2022 | 6 | |
| 18 | 2024 | 6 | |
| 19 | 2025 | 6 | |
| 20 | 2025 | 4 |
About Elham Rismani
Elham Rismani is a scholar working on Molecular Biology, Biomaterials, Hepatology, Clinical Biochemistry and Oncology, having authored 39 papers that have together received 319 indexed citations. Recurring topics across this work include Wnt/β-catenin signaling in development and cancer (5 papers), Nanoparticle-Based Drug Delivery (4 papers), Protein Structure and Dynamics (4 papers), vaccines and immunoinformatics approaches (4 papers), Cancer Cells and Metastasis (3 papers), Computational Drug Discovery Methods (3 papers), Pluripotent Stem Cells Research (3 papers) and Metabolism and Genetic Disorders (3 papers). The work is most often cited by research in Biomaterials (81 citations), Drug Discovery (1 citation), Molecular Medicine (15 citations), Pharmaceutical Science (14 citations) and Oncology (35 citations). Elham Rismani has collaborated with scholars based in Iran, Sweden and Türkiye. Frequent co-authors include Behrooz Johari, Yousef Mortazavi, Mehdi Kadivar, Mahmoud Gharbavi, Ali Sharafi, Ladan Teimoori‐Toolabi, Navid Mousazadeh, Hamzeh Rahimi, Amir Hossein Taromchi and Ladan Mafakher. Their work appears in journals such as Journal of Biomolecular Structure and Dynamics, Cell Biology International, Scientific Reports, Journal of Molecular Graphics and Modelling and Journal of Cellular Physiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.